Parfrey Ps

805 total citations
24 papers, 574 citations indexed

About

Parfrey Ps is a scholar working on Nephrology, Pathology and Forensic Medicine and General Health Professions. According to data from OpenAlex, Parfrey Ps has authored 24 papers receiving a total of 574 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Nephrology, 4 papers in Pathology and Forensic Medicine and 4 papers in General Health Professions. Recurrent topics in Parfrey Ps's work include Dialysis and Renal Disease Management (10 papers), Chronic Kidney Disease and Diabetes (3 papers) and Erythropoietin and Anemia Treatment (3 papers). Parfrey Ps is often cited by papers focused on Dialysis and Renal Disease Management (10 papers), Chronic Kidney Disease and Diabetes (3 papers) and Erythropoietin and Anemia Treatment (3 papers). Parfrey Ps collaborates with scholars based in Canada, United Kingdom and United States. Parfrey Ps's co-authors include Donna Hefferton, Emanuel Kanal, Barkovich Aj, Brown Jj, Richard H. Cohan, Susan Stuckless, William J. McKenna, Brian Gallagher, Nancy D. Merner and Alan M. Haywood and has published in prestigious journals such as American Journal of Kidney Diseases, Nephrology Dialysis Transplantation and Value in Health.

In The Last Decade

Parfrey Ps

24 papers receiving 554 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Parfrey Ps Canada	13	238	116	79	73	70	24	574
Yung Ly Kim South Korea	11	186 0.8×	59 0.5×	112 1.4×	45 0.6×	67 1.0×	16	483
Abdülkadir Ünsal Türkiye	16	406 1.7×	98 0.8×	103 1.3×	52 0.7×	141 2.0×	63	741
Salih İnal Türkiye	12	180 0.8×	59 0.5×	39 0.5×	34 0.5×	70 1.0×	29	412
Helena Strevens Sweden	15	209 0.9×	106 0.9×	118 1.5×	20 0.3×	77 1.1×	40	902
Sadollah Abedini Norway	11	174 0.7×	77 0.7×	125 1.6×	27 0.4×	123 1.8×	23	483
M. Carmody Ireland	12	151 0.6×	65 0.6×	136 1.7×	39 0.5×	69 1.0×	48	412
David Tovbin Israel	15	144 0.6×	39 0.3×	75 0.9×	28 0.4×	64 0.9×	41	622
Tae Ryom Oh South Korea	13	263 1.1×	106 0.9×	53 0.7×	44 0.6×	100 1.4×	58	536
Lourdes Craver Spain	14	410 1.7×	110 0.9×	231 2.9×	250 3.4×	140 2.0×	24	824
Frank Bruns Germany	13	164 0.7×	82 0.7×	191 2.4×	45 0.6×	201 2.9×	22	543

Countries citing papers authored by Parfrey Ps

Since Specialization

Citations

This map shows the geographic impact of Parfrey Ps's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Parfrey Ps with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Parfrey Ps more than expected).

Fields of papers citing papers by Parfrey Ps

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Parfrey Ps. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Parfrey Ps. The network helps show where Parfrey Ps may publish in the future.

Co-authorship network of co-authors of Parfrey Ps

This figure shows the co-authorship network connecting the top 25 collaborators of Parfrey Ps. A scholar is included among the top collaborators of Parfrey Ps based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Parfrey Ps. Parfrey Ps is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Stollenwerk, Björn, Sergio Iannazzo, Ron Akehurst, et al.. (2016). Assessing The Cost-Utility of Etelcalcetide: A Markov Model. Value in Health. 19(7). A519–A519. 2 indexed citations

Ps, Parfrey, et al.. (2014). Responsiveness of the patient's perception of hemodialysis scale.. PubMed. 24(2). 33–44. 2 indexed citations

Stuckless, Susan, Julie Green, Lesa Dawson, et al.. (2012). Impact of gynecological screening in Lynch syndrome carriers with an MSH2 mutation. Clinical Genetics. 83(4). 359–364. 25 indexed citations

Stuckless, Susan, et al.. (2011). Impact of colonoscopic screening in male and female Lynch syndrome carriers with an MSH2 mutation. Clinical Genetics. 82(5). 439–445. 42 indexed citations

Jj, Brown, et al.. (2009). Merten GJ, Burgess WP, Gray LV, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate: A randomized controlled trial. JAMA 2004; 291: 2328-2334. Tepel M, van der Giet M, Schwarzfeld C, Laufer U, Liermann D, Zidek W. Prevention of Radiographic-Contrast-Agent-Induced Reductions in Renal Function by Acetylcysteine. N Engl J Med 2000;343(3):180-184.. 121 indexed citations

Moore, S. Jo, H. Dawn Marshall, Leslie Steele, et al.. (2008). The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland. Clinical Genetics. 74(3). 213–222. 51 indexed citations

Ravani, Pietro, Parfrey Ps, S. Murphy, Veeresh Gadag, & Brendan J. Barrett. (2007). Clinical research of kidney diseases IV: standard regression models. Nephrology Dialysis Transplantation. 23(2). 475–482. 7 indexed citations

Ps, Parfrey. (2001). Anaemia in chronic renal disease: lessons learned since Seville 1994. Nephrology Dialysis Transplantation. 16(suppl 7). 41–45. 20 indexed citations

Ps, Parfrey, et al.. (2000). The impact of anemia correction on cardiovascular disease in end-stage renal disease.. PubMed. 20(4). 350–5. 20 indexed citations

10.

Ps, Parfrey, et al.. (1998). Screening and treatment for cardiovascular disease in patients with chronic renal disease. American Journal of Kidney Diseases. 32(5). S184–S199. 29 indexed citations

11.

Hefferton, Donna, et al.. (1998). Higher risk for renal failure in first-degree relatives of white patients with end-stage renal disease: A population-based study. American Journal of Kidney Diseases. 32(5). 794–801. 67 indexed citations

12.

Ps, Parfrey, et al.. (1996). Concurrent utilization review and inappropriate hospital stay: evaluation of a program.. PubMed. 19(1). 28–35. 1 indexed citations

13.

Ps, Parfrey, et al.. (1994). Cardiac disease in uremia.. PubMed. 14(3). 245–52. 12 indexed citations

14.

Ps, Parfrey, et al.. (1994). The feasibility and efficacy of early discharge planning initiated by the admitting department in two acute care hospitals.. PubMed. 17(2). 88–96. 22 indexed citations

15.

Ps, Parfrey. (1994). Clinical epidemiology in chronic uremia.. PubMed. 17(5). 466–73. 3 indexed citations

16.

Ps, Parfrey, et al.. (1994). Long-term cardiac morbidity and mortality during dialysis therapy.. PubMed. 23. 311–30. 23 indexed citations

17.

Ps, Parfrey, et al.. (1988). A prospective study of health status in dialysis and transplant patients.. PubMed. 20(6). 1231–2. 20 indexed citations

18.

Ps, Parfrey, et al.. (1987). Symptoms in end-stage renal disease: dialysis v transplantation.. PubMed. 19(4). 3407–9. 20 indexed citations

19.

Ps, Parfrey, et al.. (1985). The prognostic value of renal allograft biopsy in acute rejection.. PubMed. 17(4). 1951–4. 1 indexed citations

20.

Ps, Parfrey. (1982). The nephrotic syndrome.. PubMed. 27(2). 155–62. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact